Key Developments: CVS Health Corp (CVS.N)

CVS.N on New York Stock Exchange

102.26USD
1 Apr 2015
Change (% chg)

$-0.95 (-0.92%)
Prev Close
$103.21
Open
$102.47
Day's High
$102.72
Day's Low
$101.32
Volume
1,243,133
Avg. Vol
1,378,966
52-wk High
$105.45
52-wk Low
$72.37

Search Stocks

Latest Key Developments (Source: Significant Developments)

CVS Caremark Corp announces new clinical affiliation with MedStar Health
Wednesday, 27 Aug 2014 08:30am EDT 

CVS Caremark Corp:Announced it has entered into new clinical affiliation with MedStar Health, health care system with ten hospitals in Maryland and Washington, DC, region, which will enhance access to high-quality, affordable health care services for patients.Says through this clinical affiliation, MedStar Health patients will continue to have access to clinical support, medication counseling, chronic disease monitoring and wellness programs at CVS/pharmacy stores and MinuteClinic, the retail health care division of CVS Caremark.In addition, CVS Caremark will provide critical prescription and visit information to affiliated health care providers through integration of secured electronic medical record (EMR) systems.  Full Article

CVS Caremark Corp raises FY 2014 EPS guidance; gives Q3 2014 EPS guidance in line with analysts' estimates
Tuesday, 5 Aug 2014 07:00am EDT 

CVS Caremark Corp:Raises and narrows FY 2014 adjusted EPS range to $4.43 to $4.51, up from $4.36 to $4.50.Raises and narrows FY 2014 GAAP diluted EPS from continuing operations range to $4.16 to $4.24, up from $4.09 to $4.23.Expects Q3 2014 adjusted EPS guidance of $1.11 to $1.14 and GAAP diluted EPS from continuing operations guidance of $1.04 to $1.07.FY 2014 EPS of $4.46 and Q3 2014 EPS of $1.13 - Thomson Reuters I/B/E/S.  Full Article

Cvs Caremark Corp to purchase Navarro Discount Pharmacy
Monday, 14 Jul 2014 04:10pm EDT 

Cvs Caremark Corp:Enters into definitive agreement to acquire assets of Miami-based Navarro Discount Pharmacy, Hispanic-owned drugstore chain in U.S.Transaction includes Navarro's 33 retail drugstore locations and Navarro Health Services, specialty pharmacy serving patients with complex or chronic diseases.Upon completion of transaction, acquired stores will remain under Navarro Discount Pharmacy brand.Financial terms of the agreement were not disclosed.  Full Article

Cvs Caremark Corp approves quarterly dividend
Thursday, 10 Jul 2014 12:57pm EDT 

Cvs Caremark Corp:Approves quarterly dividend of $0.275 (27.5 cents) per share on the corporation's common stock.Dividend is payable on Aug. 1, 2014, to holders of record on July 21, 2014.  Full Article

Cvs Caremark Corp reaffirms FY 2014 EPS outlook; gives Q2 2014 EPS outlook in line with analysts' estimates
Friday, 2 May 2014 07:01am EDT 

Cvs Caremark Corp:Confirmed FY 2014 adjusted EPS range of $4.36 to $4.50.FY 2014 GAAP diluted EPS from continuing operations range to $4.09 to $4.23.FY 2014 EPS of $4.47 - Thomson Reuters I/B/E/S.Sees Q2 2014 adjusted EPS of $1.08 to $1.11.Q2 2014 GAAP diluted EPS from continuing operations of $1.01 to $1.04.Q2 2014 EPS of $1.09 - Thomson Reuters I/B/E/S.  Full Article

Cvs Caremark Corp to pay $20 mln to settle SEC fraud charges
Tuesday, 8 Apr 2014 03:54pm EDT 

Cvs Caremark Corp:Will pay $20 mln to settle U.S. Securities and Exchange Commission charges that it defrauded investors in 2009 during a debt offering and by accounting improperly for an acquisition.  Full Article

Cvs Caremark Corp announces quarterly dividend
Thursday, 6 Mar 2014 02:14pm EST 

Cvs Caremark Corp:Declares a quarterly dividend of $0.275 per share.Payable on May 2, to holders of record on Apr. 22.  Full Article

Cvs Caremark Corp's MinuteClinic and Robert Wood Johnson University Hospital agree to clinical collaboration in Central New Jersey
Thursday, 6 Mar 2014 08:00am EST 

Cvs Caremark Corp:Says MinuteClinic, the retail health care division of CVS Caremark and Robert Wood Johnson University Hospital (RWJ), one of the academic medical centers.Have signed a clinical collaboration to enhance access to health care services at MinuteClinic walk-in medical clinics inside select CVS/pharmacy stores in New Jersey's Middlesex and Mercer counties.Under the agreement, MinuteClinic and RWJ will collaborate on patient education and disease management initiatives and will inform patients of the services each offer at the MinuteClinic locations open seven days a week inside three CVS/pharmacy stores in East Brunswick, Old Bridge and Plainsboro.In addition, RWJ primary care providers will serve as collaborating physicians for MinuteClinic nurse practitioners working in these locations.The collaboration includes plans for future clinics in the two counties as part of MinuteClinic's national expansion plan to add 150 new clinics in 2014 and reach a total of 1,500 clinics in the U.S. by 2017.  Full Article

Cvs Caremark Corp's MinuteClinic and Main Line Health agree to clinical collaboration in Southeastern Pennsylvania
Wednesday, 5 Mar 2014 08:00am EST 

Cvs Caremark Corp:Says its retail health care division MinuteClinic and Main Line Health have signed a clinical collaboration at MinuteClinic walk-in medical clinics inside select CVS/pharmacy stores in Southeastern Pennsylvania.Under the agreement, physicians from Main Line Health's multi-specialty physician network, with more than 2,000 doctors, will serve as collaborating physicians for MinuteClinic locations in Chester, Delaware and Montgomery counties.Collaboration will include future clinics as part of MinuteClinic's national expansion plan to add 150 new clinics this year and reach a total of 1,500 clinics in the U.S. by 2017.  Full Article

Cvs Caremark Corp reaffirms FY 2014 EPS guidance; raises Q1 2014 EPS guidance
Tuesday, 11 Feb 2014 07:05am EST 

Cvs Caremark Corp:Reaffirmed FY 2014 EPS guidance.Expects FY 2014 adjusted EPS in the range of $4.36-$4.50.Expects FY 2014 GAAP EPS in the range of $4.09-$4.23.Raised Q1 2014 EPS guidance.Expects Q1 2014 adjusted EPS in the range of $1.03-$1.06.Expects Q1 2014 GAAP EPS in the range of $0.97-$1.00.FY 2014 EPS of $4.47 - Thomson Reuters I/B/E/S.Q1 2014 EPS of $0.98 - Thomson Reuters I/B/E/S.  Full Article

Photo

Exclusive: CVS says biotech drug copies may bring price cuts of 40-50 percent

WASHINGTON - The entry of copycat biotech drugs into the U.S. market could cut prices of expensive medications by 40 percent to 50 percent, depending on the level of competition among drugmakers, a top executive at CVS Health Corp told Reuters.

Search Stocks